Gastrointestinal Endoscopy
Volume 71, Issue 1 , Pages 44-49 , January 2010

Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease

Received 16 September 2008 ,Accepted 10 April 2009.

References 

  1. Remuzzi G. Bleeding in renal failure. Lancet. 1988;1:1205–1208
  2. Weigert AL, Schafer AI. Uremic bleeding: pathogenesis and therapy. Am J Med Sci. 1998;316:94–104
  3. Chalasani N, Cotsonis G, Wilcox C. Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol. 1996;91:2329–2332
  4. Rockall T, Logan F, Devlin H, et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316–321
  5. Lau J, Sung J, Lee K, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343:310–316
  6. Calvet X, Vergera M, Brullet E, et al. Addition of a second endoscopic treatment following epinephrine injection improves outcome in high risk bleeding ulcers. Gastroenterology. 2004;126:441–450
  7. Levey AS, Coresh J, Balk E, et al. National kidney foundation practice guidelines for CKD: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
  8. Sabovic M, Lavre J, Vujkovac B. Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrol Dial Transplant. 2003;18:1388–1391
  9. Boccardo P, Remuzzi G, Galbursera M. Platelet dysfunction in renal failure. Semin Thromb Hemost. 2004;30:579–589
  10. Sung J, Chan F, Lau J, et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots. Ann Intern Med. 2003;139:237–243
  11. Javid G, Masoodi I, Zargar A, et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med. 2001;111:280–284
  12. Lai K, Hui W, Wong B, et al. A retrospective and prospective study on the safety of discharging selected patients with duodenal ulcer bleeding on the same day as endoscopy. Gastrointest Endosc. 1997;45:26–30
  13. Sreedhara R, Itagaki I, Lynn B, et al. Defective platelet aggregation in uremia is transiently worsened by hemodialysis. Am J Kidney Dis. 1995;25:555–563
  14. Remuzzi G, Benigni A, Dodesini P, et al. Platelet function in patients on maintenance hemodialysis: depressed or enhanced?. Clin Nephrol. 1982;17:60–63
  15. Remuzzi G, Livio E, Marchiaro G, et al. Altered platelet function in chronic uraemia only partially corrected by hemodialysis. Nephron. 1978;22:347–353
  16. Mannucci P, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens bleeding time in uremia. N Engl J Med. 1983;308:8–12
  17. Mannucci P. Desmopressin in the treatment of bleeding disorders: the first 20 years. Blood. 1997;90:2515–2521
  18. Dinoso VP, Murthy SN, Saris AL, et al. Gastric and pancreatic function in patients with end-stage renal disease. J Clin Gastroenterol. 1982;4:321–324
  19. McConnell J, Stewart WK, Thojodeliefsson B, et al. Gastric function in chronic renal failure. Effects of maintenance haemodialysis. Lancet. 1975;2:1121–1123
  20. Sullivan SN, Tustanoff E, Slaughter DN, et al. Hypergastrinemia and gastric acid hypersecretion in uremia. Clin Nephrol. 1976;5:25–28
  21. Barkun A, Sabbah S, Enns R, et al. The Canadian registry on nonvariceal upper gastrointestinal bleeding and endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol. 2004;99:1238–1246

 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.

 See CME section; p. 139

PII: S0016-5107(09)01758-1

doi: 10.1016/j.gie.2009.04.014

Gastrointestinal Endoscopy
Volume 71, Issue 1 , Pages 44-49 , January 2010

Article Tools

* Image Usage & Resolution